C/EBPα in leukemogenesis: Identity and origin of the leukemia-initiating cell

BioFactors

Volumn 35, Issue 3, 2009, Pages 227-231

  Schuster, Mikkel Bruhn ^a,b   Porse, Bo Torben ^a,b  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

C EBP ; Cancer stem cell; Hematopoiesis; Leukemia

Indexed keywords

ENHANCER BINDING PROTEIN ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; CELL POPULATION; EPIGENETICS; GENETICS; HUMAN; LEUKEMIA CELL; LEUKEMOGENESIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; CYTOLOGY; HEMATOPOIESIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS;

EID: 69149086081     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.36     Document Type: Review

References (52)

1. McKnight, S. L. (2001) McBindall-a better name for CCAAT/enhancer binding proteins? Cell. 107, 259-261.
2. Ramji, D. P. and Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575.
3. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., and Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPαlpha regulates human granulopoiesis. Cell. 123, 819-831.
4. Heath, V., Suh, H. C., Holman, M., Renn, K., Gooya, J. M., et al. (2004) C/EBPαlpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood. 104, 1639-1647.
5. Iwama, A., Osawa, M., Hirasawa, R., Uchiyama, N., Kaneko, S., Onodera, M., Shibuya, K., Shibuya, A., Vinson, C., Tenen, D. G., and Nakauchi, H. (2002) Reciprocal roles for CCAAT/enhancer binding protein (C/ EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195, 547-558.
6. Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., and Tenen, D. G. (1998) CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301-4314.
7. Schuster, M. B. and Porse, B. T. (2006) C/EBPαlpha: a tumour suppressor in multiple tissues? Biochim. Biophys. Acta. 1766, 88-103.
8. Wang, X., Scott, E., Sawyers, C. L., and Friedman, A. D. (1999) C/EBPαlpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood. 94, 560-571.
9. Zhang, D. E., Zhang, P., Wang, N. D., Hetherington, C. J., Darlington, G. J., and Tenen, D. G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA. 94, 569-574.
10. Zhang, P., Iwama, A., Datta, M. W., Darlington, G. J., Link, D. C., and Tenen, D. G. (1998) Upregulation of interleukin 6 and granulocyte colony- stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha (C/EBP alpha) is critical for granulopoiesis. J. Exp. Med. 188, 1173-1184.
11. Zhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom- Himes, J. A., Akashi, K., and Tenen, D. G. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 21, 853-863.
12. Porse, B. T., Bryder, D., Theilgaard-Monch, K., Hasemann, M. S., Anderson, K., Damgaard, I., Jacobsen, S. E., and Nerlov, C. (2005) Loss of C/ EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J. Exp. Med. 202, 85-96.
13. Porse, B. T., Pedersen, T. A., Xu, X., Lindberg, B., Wewer, U. M., Friis- Hansen, L., and Nerlov, C. (2001) E2F repression by C/EBPαlpha is required for adipogenesis and granulopoiesis in vivo. Cell. 107, 247-258.
14. Bienz, M., Ludwig, M., Leibundgut, E. O., Mueller, B. U., Ratschiller, D., Solenthaler, M., Fey, M. F., and Pabst, T. (2005) Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin. Cancer. Res. 11, 1416-1424.
15. Frohling, S., Schlenk, R. F., Krauter, J., Thiede, C., Ehninger, G., Haase, D., Harder, L., Kreitmeier, S., Scholl, C., Caligiuri, M. A., Bloomfield, C. D., Dohner, H., and Dohner, K. (2005) Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA lossof-function mutations. Genes. Chromosomes. Cancer. 42, 427-432.
16. Frohling, S., Schlenk, R. F., Stolze, I., Bihlmayr, J., Benner, A., Kreitmeier, S., Tobis, K., Dohner, H., and Dohner, K. (2004) Mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J. Clin. Oncol. 22, 624-633.
17. Gombart, A. F., Hofmann, W. K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, R. J., Asou, H., Miller, C. W., Hoelzer, D., and Koeffler, H. P. (2002) Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood. 99, 1332-1340.
18. Kaeferstein, A., Krug, U., Tiesmeier, J., Aivado, M., Faulhaber, M., Stadler, M., Krauter, J., Germing, U., Hofmann, W. K., Koeffler, H. P., Ganser, A., and Verbeek, W. (2003) The emergence of a C/EBPαlpha mutation in the clonal evolution of MDS towards secondary AML. Leukemia. 17, 343-349.
19. Leroy, H., Roumier, C., Huyghe, P., Biggio, V., Fenaux, P., and Preudhomme, C. (2005) CEBPA point mutations in hematological malignancies. Leukemia. 19, 329-334.
20. Lin, L. I., Chen, C. Y., Lin, D. T., Tsay, W., Tang, J. L., Yeh, Y. C., Shen, H. L., Su, F. H., Yao, M., Huang, S. Y., and Tien, H. F. (2005) Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin. Cancer. Res. 11, 1372-1379.
21. Mueller, B. U. and Pabst, T. (2006) C/EBPαlpha and the pathophysiology of acute myeloid leukemia. Curr. Opin. Hematol. 13, 7-14
22. Nerlov, C. (2004) C/EBPαlpha mutations in acute myeloid leukaemias. Nat. Rev. Cancer.4, 394-400.
23. Pabst, T., Eyholzer, M., Haefliger, S., Schardt, J., and Mueller, B. U. (2008) Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. J. Clin. Oncol. 26, 5088-5093.
24. Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., and Tenen, D. G. (2001) Dominant- negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPαlpha), in acute myeloid leukemia. Nat. Genet. 27, 263-270.
25. Preudhomme, C., Sagot, C., Boissel, N., Cayuela, J. M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., Fenaux, P., and Dombret, H. (2002) Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood. 100, 2717-2723.
26. Sellick, G. S., Spendlove, H. E., Catovsky, D., Pritchard-Jones, K., and Houlston, R. S. (2005) Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia. 19, 1276-1278.
27. Shih, L. Y., Huang, C. F., Lin, T. L., Wu, J. H., Wang, P. N., Dunn, P., Kuo, M. C., and Tang, T. C. (2005) Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Clin. Cancer. Res. 11, 1821-1826.
28. Smith, M. L., Cavenagh, J. D., Lister, T. A., and Fitzgibbon, J. (2004) Mutation of CEBPA in familial acute myeloid leukemia. N. Engl. J. Med. 351, 2403-2407.
29. Snaddon, J., Smith, M. L., Neat, M., Cambal-Parrales, M., Dixon-McIver, A., Arch, R., Amess, J. A., Rohatiner, A. Z., Lister, T. A., and Fitzgibbon, J. (2003) Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Genes. Chromosomes. Cancer. 37, 72-78
30. Tiesmeier, J., Czwalinna, A., Muller-Tidow, C., Krauter, J., Serve, H., Heil, G., Ganser, A., and Verbeek, W. (2003) Evidence for allelic evolution of C/EBPαlpha mutations in acute myeloid leukaemia. Br. J. Haematol. 123, 413-419.
31. van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L., Valk, P. J., Berna Beverloo, H., Tenen, D. G., Lowenberg, B., and Delwel, R. (2003) Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. Hematol. J. 4, 31-40.
32. Kirstetter, P., Schuster, M. B., Bereshchenko, O., Moore, S., Dvinge, H., Kurz, E., Theilgaard-Monch, K., Mansson, R., Pedersen, T. A., Pabst, T., Schrock, E., Porse, B. T., Jacobsen, S. E., Bertone, P., Tenen, D. G., and Nerlov, C. (2008) Modeling of C/EBPαlpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia- initiating cells. Cancer. Cell. 13, 299-310.
33. Hackanson, B., Bennett, K. L., Brena, R. M., Jiang, J., Claus, R., Chen, S. S., Blagitko-Dorfs, N., Maharry, K., Whitman, S. P., Schmittgen, T. D., Lubbert, M., Marcucci, G., Bloomfield, C. D., and Plass, C. (2008) Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer. Res. 68, 3142-3151.
34. Jost, E. O. N. D., Wilop, S., Herman, J. G., Osieka, R., and Galm, O. Aberrant DNA methylation of the transcription factor C/EBPαlpha in acute myelogenous leukemia. Leuk. Res., in press.
35. Ayton, P. M. and Cleary, M. L. (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes. Dev. 17, 2298-2307.
36. Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M., and Sutherland, H. J. (1997) Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood. 89, 3104-3112.
37. Bonnet, D. and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
38. Ishikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., Fukata, M., Miyamoto, T., Lyons, B., Ohshima, K., Uchida, N., Taniguchi, S., Ohara, O., Akashi, K., Harada, M., and Shultz, L. D. (2007) Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315-1321.
39. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres- Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., and Dick, J. E. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367, 645-648.
40. Tan, B. T., Park, C. Y., Ailles, L. E., and Weissman, I. L. (2006) The cancer stem cell hypothesis: a work in progress. Lab. Invest. 86, 1203-1207.
41. Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., and Bishop, J. M. (1997) A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94, 2551-2556.
42. Jaiswal, S., Traver, D., Miyamoto, T., Akashi, K., Lagasse, E., and Weissman, I. L. (2003) Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc. Natl. Acad. Sci. USA. 100, 10002-10007.
43. Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., and Zhang, D. E. (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc. Natl. Acad. Sci. USA. 98, 10398-10403. (Pubitemid 32803031)
44. Huntly, B. J., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., Akashi, K., and Gilliland, D. G. (2004) MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer. Cell. 6, 587-596.
45. Cozzio, A., Passegue, E., Ayton, P. M., Karsunky, H., Cleary, M. L., and Weissman, I. L. (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes. Dev. 17, 3029-3035.
46. Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., Golub, T. R., and Armstrong, S. A. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 442, 818-822.
47. Chen, W., Kumar, A. R., Hudson, W. A., Li, Q., Wu, B., Staggs, R. A., Lund, E. A., Sam, T. N., and Kersey, J. H. (2008) Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer. Cell. 13, 432-440.
48. Wong, P., Iwasaki, M., Somervaille, T. C., So, C. W., and Cleary, M. L. (2007) Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes. Dev. 21, 2762-2774.
49. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., Dohy, H., and Niho, Y. (1996) Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood. 87, 4789-4796.
50. Miyamoto, T., Weissman, I. L., and Akashi, K. (2000) AML1/ETOexpressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA. 97, 7521-7526.
51. Mori, H., Colman, S. M., Xiao, Z., Ford, A. M., Healy, L. E., Donaldson, C., Hows, J. M., Navarrete, C., and Greaves, M. (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA. 99, 8242-8247.
52. Nerlov, C. (2007) The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends. Cell. Biol. 17, 318-324.